Company / Total Debt
Esperion Therapeutics, Inc. Total Debt History
FY2016-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$1.0M
FY2016
5-year range
-
FY2016-FY2016
Trend
-62.0%
vs FY2015
Sector context
#80 of 83
Health Care
What the data says
Among 83 Health Care companies, Esperion Therapeutics, Inc. is in the top 4% for total debt.
Based on SEC 10-K filings.
$1M in FY2016.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 83This company $1.0M Sector average $6.2B
▼
-100.0% below sector average
Company context
Key Data Points
- Altman Z-Score -1.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $1.0M | -62.0% |
As of FY2016 · SEC 10-K · Updated Jul 2, 2026